Eli Lilly and Company (LLY) Stock | Share Price | US5324571083
LLY · Health Care ·
United States
Eli Lilly and Company (LLY) is a company in the Health Care sector, based in United States. The stock is held in 22 ETFs we track – with its largest weight of 15.36 % in XUHC (msci-usa-health-care). That means you can hold Eli Lilly and Company indirectly and diversified through an ETF savings plan.
Very high ETF coverage: 22 of the 95 ETFs we cover hold Eli Lilly and Company, spread across 10 indices. That puts the stock in more ETFs than 90.0 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | +10.1 % | 1 year | +61.6 % |
|---|---|---|---|
| 1 month | -0.7 % | 3 months | +9.8 % |
| Calendar year 2025 | +39.2 % | ||
| Calendar year 2026 | +10.7 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Johnson & Johnson | +0.57 | |
| Vertex Pharmaceuticals Incorporated | +0.53 | |
| AbbVie Inc. | +0.51 | |
| Amgen Inc. | +0.49 | |
| Royalty Pharma plc Class A | +0.48 | |
| Pfizer Inc. | +0.47 | |
| Hubbell Incorporated | -0.35 | |
| Keysight Technologies Inc | -0.27 | |
| NVIDIA Corporation | -0.27 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 34.1 | 5.2 | 15.4 % |
| FY2024 | 45.0 | 10.6 | 23.5 % |
| FY2025 | 65.2 | 20.6 | 31.7 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 15.36 % |
| XUHL | msci-usa-health-care | 15.36 % |
| XDWH | msci-world-health-care | 11.26 % |
| SPFS | msci-world-health-care | 11.01 % |
| XDEQ | msci-world-quality | 2.61 % |
| IS3Q | msci-world-quality | 2.45 % |
| XD9U | msci-usa | 1.49 % |
| XD9D | msci-usa | 1.49 % |
| SXR8 | sp500 | 1.48 % |
| SPYL | sp500 | 1.42 % |
| SPY5 | sp500 | 1.42 % |
| XDWD | msci-world | 1.08 % |
| XDWL | msci-world | 1.08 % |
| EUNL | msci-world | 1.07 % |
| SPPW | msci-world | 1.04 % |
| SWWD | msci-world | 1.04 % |
| WIMI | msci-world-imi | 0.96 % |
| IUSQ | msci-acwi | 0.95 % |
| SPYY | msci-acwi | 0.92 % |
| SPYI | msci-acwi-imi | 0.80 % |
| SPSA | msci-acwi-imi | 0.80 % |
| XDEB | msci-world-minimum-volatility | 0.37 % |
Want to know how much Eli Lilly and Company overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Eli Lilly and Company — the figure counts the ETFs holding both.
AbbVie Inc.ABBV · 20 shared ETFs · r +0.51
Abbott LaboratoriesABT · 20 shared ETFs
Boston Scientific CorporationBSX · 20 shared ETFs
Cardinal Health Inc.CAH · 20 shared ETFs
Cencora Inc.COR · 20 shared ETFs
McKesson CorporationMCK · 20 shared ETFs
ResMed Inc.RMD · 20 shared ETFs
Johnson & JohnsonJNJ · 21 shared ETFs · r +0.57
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026